Rejuvenating cellular respiration for optimizing respiratory function: targeting mitochondria.

Area of Science:

• Mitochondrial biology and respiratory medicine

Background:

• Altered cellular energy production and increased oxidative stress in mitochondria are central to lung diseases such as asthma and COPD.
• Mitochondrial dysfunction also impacts vascular and systemic health in lung disease patients.
• These issues are observed across various lung conditions, including pulmonary fibrosis and bronchopulmonary dysplasia.

Purpose of the Study:

• To review the critical role of mitochondrial function in lung health and disease.
• To explore mitochondria-targeted therapeutic strategies for respiratory diseases.
• To highlight a "3R" model (repair, reprogramming, replacement) for these therapies.

Main Methods:

• Review of experimental models for COPD, asthma, pulmonary fibrosis, and acute lung injury.
• Analysis of studies using mitochondria-targeted antioxidants (e.g., MitoQ).
• Examination of research on noncoding RNA and protein regulators of mitochondrial dynamics.
• Evaluation of studies involving healthy mitochondria transfer to epithelial cells.

Main Results:

• Mitochondria-targeted antioxidants improved mitochondrial health and respiratory function in experimental COPD and asthma.
• Modulating mitochondrial regulators proved effective in models of fibrosis, emphysema, asthma, and pulmonary hypertension.
• Mitochondria transfer demonstrated significant therapeutic effects in acute lung injury and asthma models.

Conclusions:

• Mitochondrial health is crucial for preventing and treating lung diseases.
• Mitochondria-targeted therapies offer a promising approach for lung disease management.
• The "3R" model provides a framework for developing novel mitochondrial rejuvenation strategies.